Alosetron in irritable bowel syndrome
- PMID: 10963271
- DOI: 10.1016/S0140-6736(05)73177-9
Alosetron in irritable bowel syndrome
Comment in
-
Lotronex and the FDA: a fatal erosion of integrity.Lancet. 2001 May 19;357(9268):1544-5. doi: 10.1016/S0140-6736(00)04776-0. Lancet. 2001. PMID: 11377636 No abstract available.
Comment on
-
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.Lancet. 2000 Mar 25;355(9209):1035-40. doi: 10.1016/S0140-6736(00)02033-X. Lancet. 2000. PMID: 10744088 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
